10 completed. 10 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 10 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Osteo Arthritis Knee: new trials by email Literature Review of Osteo Arthritis Knee trials Research Report on Osteo Arthritis Knee
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis Sustained Acoustic Device with 2.5% Diclofenac Patch, Sustained Acoustic Device with 0% Diclofenac Patch, 2.5% Diclofenac Patches - Osteo Arthritis Knee, Arthritis | Phase 2 | Completed | ZetrOZ, Inc. | 307 | 2024-10-01 | 2026-06-30 |
| A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) - Osteo Arthritis Knee | Phase 1 / Phase 2 | Completed | Cellcolabs Clinical SPV Limited | 12 | 2023-11-07 | 2026-04-16 |
| Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis Sustained Acoustic Device with 2.5% Diclofenac Patch, Sustained Acoustic Device with 0% Diclofenac Patch, 2.5% Diclofenac Patches - Osteo Arthritis Knee, Arthritis | Phase 2 | Completed | ZetrOZ, Inc. | 200 | 2023-06-03 | 2025-05-15 |
| Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee LEVI-04, Placebo - Pain, Osteo Arthritis Knee | Phase 2 | Completed | Levicept | 518 | 2022-10-19 | 2025-11-20 |
| Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee Duloxetine 30 MG, Nonsteroidal Antiinflammatory Drug - Osteo Arthritis Knee | Phase 2 | Completed | Hawler Medical University | 200 | 2022-08-20 | 2023-03-14 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis LY3526318, Placebo - Osteoarthritis, Osteo Arthritis Knee | Phase 2 | Completed | Eli Lilly and Company | 160 | 2021-10-12 | 2024-07-17 |
| pAF for the Treatment of Osteoarthritis Amniotic Fluid Injection, Standard of Care - Osteo Arthritis Knee | Phase 1 / Phase 2 | Completed | University of Utah | 60 | 2021-07-08 | 2026-03-27 |
| Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, Corticosteroid - Osteo Arthritis Knee | Phase 2 / Phase 3 | Completed | Queen Savang Vadhana Memorial Hospital, Thailand | 93 | 2020-08-03 | 2023-02-21 |
| Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis allogenic lyophilized growth factors - Osteo Arthritis Knee | Phase 2 | Completed | Rasmia Elgohary | 31 | 2017-05-01 | 2021-01-28 |
| A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the Knee V120083, Naproxen, Placebo - Osteo Arthritis Knee | Phase 2 | Completed | Purdue Pharma LP | 291 | 2017-03-14 | 2019-02-12 |
Osteoarthritis (5) · Arthritis (3) · Osteoarthritis, Knee (3) · Pain (2) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Rheumatic Diseases (1)
Joint Diseases (7) · Musculoskeletal Diseases (7) · Arthritis (5) · Rheumatic Diseases (5) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Connective Tissue Diseases (1) · Osteoarthritis (1) · Skin and Connective Tissue Diseases (1)
Adrenal Cortex Hormones (1) · Anti-Inflammatory Agents, Non-Steroidal (1) · Duloxetine Hydrochloride (1) · MICU1 protein, human (1) · Naproxen (1) · Platelet Activating Factor (1) · Standard of Care (1)
ZetrOZ, Inc. (2) · Cellcolabs Clinical SPV Limited (1) · Eli Lilly and Company (1) · Hawler Medical University (1) · Levicept (1) · Purdue Pharma LP (1) · Queen Savang Vadhana Memorial Hospital, Thailand (1) · Rasmia Elgohary (1) · University of Utah (1)
United States (5) · Czechia (1) · Denmark (1) · Egypt (1) · Hong Kong (1) · Iraq (1) · Moldova (1) · Poland (1) · Puerto Rico (1) · Thailand (1) · United Arab Emirates (1)
George K Lewis, Ph.D. (2) · David Petron, MD (1) · Fahti Yousef, PhD (1) · Kamel Gado, MD (1) · Niaz Albarzinji, MBCHB,DRMR (1) · Simon Westbrook (1) · Surapol Athiprayul, MD (1)
PMID 12081113, PMID 1991946, PMID 25035839, PMID 25161985, PMID 25925602, PMID 26432430, PMID 28012636, PMID 28386761, PMID 30623236, PMID 30632533, PMID 33754800, PMID 34826301, PMID 35103547, PMID 41905364